Skip to content

Development of an Intervention Program for Barriers to Adherence to Complete Decongestive Therapy in Patients with Breast Cancer-Related Lymphedema After Surgery Based on the Health Action Process Approach (HAPA)

Development of an Intervention Program for Barriers to Adherence to Complete Decongestive Therapy in Patients with Breast Cancer-Related Lymphedema After Surgery Based on the Health Action Process Approach (HAPA)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600128349
Enrollment
Unknown
Registered
2026-07-17
Start date
2024-07-08
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper-limb lymphedema after breast cancer surgery

Interventions

Experimental group:A HAPA-based intervention program
Control group:Routine nursing care measures

Sponsors

The First Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Has been diagnosed with breast cancer and has undergone surgical treatment; 2. The circumference measurement results indicate mild, moderate, or severe edema, and comprehensive home-based de-swelling treatment is currently underway; 3. The comprehensive de-swelling treatment for lymphedema after breast cancer surgery has lasted for more than 3 months; 4. Age is over 18 years old, with clear consciousness and the ability to communicate normally; 5. No other serious diseases or complications; 6. Signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Unable to cooperate with the research, such as severe cognitive impairments, etc.; 2. Unable to persist in completing the research, such as frequent absences, etc.

Design outcomes

Primary

MeasureTime frame
Adherence Questionnaire for Complete Decongestive Therapy in Patients with Postoperative Breast Cancer-Related Lymphedema;

Secondary

MeasureTime frame
The degree of improvement in therapeutic effect;The degree of improvement in quality of life;The degree of improvement in mental health;

Countries

China

Contacts

Public ContactFeng Yue

The First Hospital of Jilin University

576362111@qq.com+86 431 8187 5178

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026